1245646-66-5 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-2-methoxynicotinamide is used as a drug development candidate for its potential anti-inflammatory and anti-cancer properties. It has been studied for its therapeutic potential in treating asthma and inflammatory diseases, as well as its ability to inhibit the growth of certain cancer cells, indicating its potential as a chemotherapeutic agent.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-bromo-2-methoxynicotinamide is utilized for its potential to target specific biological pathways, making it a valuable compound for the design and synthesis of new drugs with improved efficacy and selectivity.
Used in Drug Discovery:
5-Bromo-2-methoxynicotinamide is employed as a lead compound in drug discovery, where its unique structure and properties can be further optimized to develop novel therapeutic agents with enhanced pharmacological profiles.
Used in Pharmacology:
In pharmacology, 5-bromo-2-methoxynicotinamide serves as a subject of research to understand its mechanism of action, pharmacokinetics, and pharmacodynamics, which can provide insights into the development of more effective and safer drugs.
Overall, 5-bromo-2-methoxynicotinamide is a promising chemical entity with diverse applications in the pharmaceutical sector, offering opportunities for the development of innovative therapeutics to address various health challenges.
Check Digit Verification of cas no
The CAS Registry Mumber 1245646-66-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,5,6,4 and 6 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1245646-66:
(9*1)+(8*2)+(7*4)+(6*5)+(5*6)+(4*4)+(3*6)+(2*6)+(1*6)=165
165 % 10 = 5
So 1245646-66-5 is a valid CAS Registry Number.
1245646-66-5Relevant academic research and scientific papers
TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
-
Paragraph 0543, (2014/08/07)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
-
Page/Page column 138, (2013/03/26)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
